GRASPA (Erythrocytes Encapsulating L-asparaginase) in Patients With Relapse of Acute Lymphoblastic Leukemia

NCT01518517 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

85

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Lymphoblastic Leukemia, in Relapse

Interventions

DRUG: GRASPA
DRUG: L-asparaginase

Sponsor

ERYtech Pharma